
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia
Thomas D. Brothers, Dan Lewer, N. R. Jones, et al.
PLoS Medicine (2022) Vol. 19, Iss. 7, pp. e1004049-e1004049
Open Access | Times Cited: 16
Thomas D. Brothers, Dan Lewer, N. R. Jones, et al.
PLoS Medicine (2022) Vol. 19, Iss. 7, pp. e1004049-e1004049
Open Access | Times Cited: 16
Showing 16 citing articles:
Author’s Response to: Wilson P, Gomes T, Guta A et al. Letter to the Editor re Kahan M. Effectiveness and Public Health Impact of Safer Supply and Opioid Agonist Treatment: A Narrative Review With Recommendations
Meldon Kahan
The Canadian Journal of Addiction (2025) Vol. 16, Iss. 1, pp. 47-48
Closed Access | Times Cited: 1
Meldon Kahan
The Canadian Journal of Addiction (2025) Vol. 16, Iss. 1, pp. 47-48
Closed Access | Times Cited: 1
Infective endocarditis: it takes a team
Lawrence Lau, Larry M. Baddour, Núria Fernández-Hidalgo, et al.
European Heart Journal (2025)
Open Access
Lawrence Lau, Larry M. Baddour, Núria Fernández-Hidalgo, et al.
European Heart Journal (2025)
Open Access
Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia
Kevin B. Laupland, Adam G. Stewart, Felicity Edwards, et al.
Infectious Diseases (2025), pp. 1-7
Open Access
Kevin B. Laupland, Adam G. Stewart, Felicity Edwards, et al.
Infectious Diseases (2025), pp. 1-7
Open Access
Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia
N. R. Jones, Fathima Nimnaz Ghouse, Amy Gibson, et al.
International Journal of Epidemiology (2025) Vol. 54, Iss. 2
Open Access
N. R. Jones, Fathima Nimnaz Ghouse, Amy Gibson, et al.
International Journal of Epidemiology (2025) Vol. 54, Iss. 2
Open Access
Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts
Simeon D. Kimmel, Alexander Y. Walley, Laura F. White, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2421740-e2421740
Open Access | Times Cited: 2
Simeon D. Kimmel, Alexander Y. Walley, Laura F. White, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2421740-e2421740
Open Access | Times Cited: 2
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia
Thomas D. Brothers, Dan Lewer, N. R. Jones, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104218-104218
Open Access | Times Cited: 4
Thomas D. Brothers, Dan Lewer, N. R. Jones, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104218-104218
Open Access | Times Cited: 4
Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: A matched cohort study
Nicole Robertson, Anthony A. Mangino, Anna-Maria South, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 160, pp. 209298-209298
Closed Access | Times Cited: 1
Nicole Robertson, Anthony A. Mangino, Anna-Maria South, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 160, pp. 209298-209298
Closed Access | Times Cited: 1
How I manage severe bacterial infections in people who inject drugs
Andrew J. Stewardson, Joshua S. Davis, Adrian Dunlop, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 7, pp. 877-882
Closed Access | Times Cited: 1
Andrew J. Stewardson, Joshua S. Davis, Adrian Dunlop, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 7, pp. 877-882
Closed Access | Times Cited: 1
Effectiveness and Public Health Impact of Safer Supply and Opioid Agonist Treatment: A Narrative Review with Recommendations
Meldon Kahan
The Canadian Journal of Addiction (2024) Vol. 15, Iss. 2, pp. 6-16
Open Access | Times Cited: 1
Meldon Kahan
The Canadian Journal of Addiction (2024) Vol. 15, Iss. 2, pp. 6-16
Open Access | Times Cited: 1
Current trends and challenges in infective endocarditis
Shivam Patel, Syed M. Ali Hassan, Michel Côté, et al.
Current Opinion in Cardiology (2024) Vol. 40, Iss. 2, pp. 75-84
Closed Access | Times Cited: 1
Shivam Patel, Syed M. Ali Hassan, Michel Côté, et al.
Current Opinion in Cardiology (2024) Vol. 40, Iss. 2, pp. 75-84
Closed Access | Times Cited: 1
Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections
Mary Figgatt, Juan M. Hincapie‐Castillo, Asher J Schranz, et al.
Epidemiology (2023) Vol. 35, Iss. 1, pp. 7-15
Closed Access | Times Cited: 2
Mary Figgatt, Juan M. Hincapie‐Castillo, Asher J Schranz, et al.
Epidemiology (2023) Vol. 35, Iss. 1, pp. 7-15
Closed Access | Times Cited: 2
Epidemiology of acute infections in people who inject drugs in Australia
Lucy O. Attwood, Daniel O’Keefe, Peter Higgs, et al.
Drug and Alcohol Review (2023) Vol. 43, Iss. 1, pp. 304-314
Open Access | Times Cited: 2
Lucy O. Attwood, Daniel O’Keefe, Peter Higgs, et al.
Drug and Alcohol Review (2023) Vol. 43, Iss. 1, pp. 304-314
Open Access | Times Cited: 2
Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject Drugs
David Goodman‐Meza, Michihiko Goto, Anabel Salimian, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 2
Open Access
David Goodman‐Meza, Michihiko Goto, Anabel Salimian, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 2
Open Access
Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis
Thomas D. Brothers, Dan Lewer, Matthew Bonn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Thomas D. Brothers, Dan Lewer, Matthew Bonn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine
Leah Harvey, Simeon D. Kimmel, E. Jennifer Edelman
Clinical Infectious Diseases (2023) Vol. 76, Iss. 7, pp. 1205-1208
Closed Access | Times Cited: 1
Leah Harvey, Simeon D. Kimmel, E. Jennifer Edelman
Clinical Infectious Diseases (2023) Vol. 76, Iss. 7, pp. 1205-1208
Closed Access | Times Cited: 1
Brothers, Thomas; Lewer, Dan; Colledge-Frisby, Samantha; Jones, Nicola; Bonn, Matthew; Wheeler, Alice; Grebely, Jason; Farrell, Michael; Hayward, Andrew; Hickman, Matthew; Degenhardt, Louisa; (2022) Time periods of altered risk for severe injection drug use-associated skin and soft-tissue infections: protocol for a self-controlled case series in New South Wales, Australia, 2001-2018
Thomas D. Brothers, Dan Lewer, N. R. Jones, et al.
(2022)
Open Access
Thomas D. Brothers, Dan Lewer, N. R. Jones, et al.
(2022)
Open Access